A Randomized, Multicenter, Double-Blind, Double Dummy, Active Comparator, Dose-Ranging Study to Explore the Efficacy of SUBSYS® in Emergency Department Patients With Acute Pain

Trial Profile

A Randomized, Multicenter, Double-Blind, Double Dummy, Active Comparator, Dose-Ranging Study to Explore the Efficacy of SUBSYS® in Emergency Department Patients With Acute Pain

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Fentanyl (Primary) ; Morphine
  • Indications Acute pain
  • Focus Therapeutic Use
  • Sponsors INSYS Therapeutics, Inc
  • Most Recent Events

    • 29 Jun 2017 Planned initiation date changed from 30 Jun 2017 to 31 Jul 2017.
    • 27 Oct 2016 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.
    • 27 Oct 2016 Planned primary completion date changed from 1 Apr 2017 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top